NCT02438904View on ClinicalTrials.gov

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 6, 2015

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
Blood And Marrow Transplantation
Interventions
BIOLOGICAL

CD34 Positive Stem Cell Infusion

Participants infused by vein with around 1 - 4 million/kg CD34+ selected cells.

DEVICE

Miltenyi device

Miltenyi device is used for CD34+ cell infusions) to patients who experience poor graft function after stem cell transplantation (SCT).

Trial Locations (1)

77030

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER